Arcadia Biosciences Inc

Arcadia Biosciences Inc

RKDA · NASDAQ · Consumer Defensive / Packaged Foods

0.218USD-0.00 (-1.80%)

Price History

Full chart

Market Stats

Previous Close0.222
Open0.2103
Day Range0.1833 – 0.2252
52-Week Range0.2786 – 5.72
Volume673.64K
Market Cap741.07K
P/E (TTM)0.00
Forward P/E36.63
EPS-4.54
Dividend Yield0.00%
Beta0.53
50-Day Avg0.5486
200-Day Avg1.37

About

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Thomas J. Schaefer C.F.A.
  • Employees8
  • Headquarters5956 Sherry Lane, Dallas, TX, United States, 75225, USA
  • Websitehttps://arcadiabio.com

Leadership

  • Mr. Thomas J. Schaefer C.F.A.CEO, Interim CFO, Principal Accounting Officer, President, Corporate Secretary & Director · b. 1976

Financials

Income Statement

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue7.01M6.48M6.98M5.41M3.19M4.03M1.46M1.17M8.03M6.78M7.42M4.45M5.04M4.86M
Growth (%)--7.59%+7.78%-22.46%-41.12%+26.29%-63.64%-20.15%+587.25%-15.61%+9.41%-39.96%+13.27%-3.71%
Cost of Revenue909.00K673.00K2.00M892.00K895.00K283.00K661.00K885.00K5.20M8.71M6.10M2.17M2.96M3.10M
Gross Profit6.10M5.80M4.99M4.52M2.29M3.74M803.00K284.00K2.83M-1.93M1.32M2.28M2.08M1.76M
Gross Margin87.03%89.61%71.40%83.52%71.93%92.97%54.85%24.29%35.29%-28.44%17.75%51.19%41.27%36.23%
Operating Expense16.23M16.37M20.14M20.09M20.91M18.06M17.67M19.66M15.61M33.60M15.32M8.38M5.73M11.76M
Operating Income-10.13M-10.57M-15.15M-15.56M-18.62M-14.31M-16.87M-19.38M-12.78M-35.53M-14.01M-6.10M-3.65M-9.99M
Operating Margin-144.51%-163.11%-217.03%-287.46%-584.07%-355.56%-1152.32%-1657.91%-159.05%-523.98%-188.82%-137.00%-72.31%-205.74%
EBITDA-9.74M-10.17M-15.39M-14.98M-17.98M-14.65M-13.32M-28.67M-5.44M-27.71M-14.75M-5.73M-7.50M-2.30M
EBITDA Margin-139.00%-156.99%-220.45%-276.65%-563.86%-364.01%-909.56%-2452.69%-67.72%-408.70%-198.83%-128.67%-148.64%-47.32%
Net Income-12.37M-13.20M-18.34M-17.96M-19.62M-15.71M-13.48M-28.80M-4.66M-14.66M-15.38M-13.98M-7.04M-2.34M
Net Income Margin-176.46%-203.69%-262.66%-331.66%-615.56%-390.14%-920.77%-2464.07%-57.94%-216.22%-207.28%-313.90%-139.50%-48.15%
R&D7.95M8.40M10.01M8.97M8.66M7.41M6.07M7.10M7.96M3.89M1.51M64.00K53.00K9.00K
R&D as % of Total Revenue113.38%129.73%143.40%165.61%271.74%183.98%414.55%607.19%99.08%57.36%20.34%1.44%1.05%0.19%
Interest Expense186.00K626.00K1.39M2.66M1.32M747.00K2.56M5.00K47.00K20.00K289.00K---
Interest Expense % of Total Revenue2.65%9.66%19.97%49.09%41.37%18.55%174.52%0.43%0.59%0.29%3.90%---

Balance Sheet

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets13.36M9.54M24.89M74.24M56.57M16.57M24.02M32.57M47.35M43.92M28.92M19.70M13.52M6.55M
Total Liabilities19.04M26.84M26.77M34.02M34.38M8.56M11.21M24.25M18.80M12.72M8.02M7.00M7.29M2.41M
Total Equity-5.68M-17.30M-1.89M40.23M22.20M8.01M12.81M7.71M27.73M31.09M21.03M12.84M6.22M4.14M
Cash5.35M2.83M16.57M23.97M2.01M9.13M12.00M8.42M14.04M28.68M20.64M6.52M4.24M259.00K
Total Debt8.00M14.56M14.47M26.93M25.13M--2.24M9.35M3.29M2.02M1.01M155.00K-
Net Debt2.65M11.73M-2.10M957.00K23.11M-9.13M-12.00M-6.18M-4.69M-25.39M-18.63M-5.51M-4.09M-259.00K

Cash Flow

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-9.59M-9.74M-14.79M-15.11M-17.05M-13.96M-13.63M-17.20M-30.22M-25.87M-13.98M-15.29M-9.63M-4.74M
Investing Cash Flow-285.00K-600.00K-1.59M-46.36M-5.30M47.18M-5.97M-8.37M17.28M16.61M1.42M-4.34M7.34M750.00K
Financing Cash Flow8.00M7.83M30.11M68.87M396.00K-26.10M22.48M21.99M20.56M21.90M4.52M5.51M9.00K6.00K
Capital Expenditure286.00K100.00K148.00K151.00K231.00K79.00K250.00K1.48M2.33M1.01M72.00K5.00K16.00K0
Free Cash Flow-9.87M-9.85M-14.94M-15.26M-17.29M-14.04M-13.88M-18.68M-32.55M-26.88M-14.05M-15.30M-9.64M-4.74M
Dividends Paid---197.00K00--------
FCF to OCF102.98%101.03%101.00%101.00%101.35%100.57%101.83%108.59%107.73%103.89%100.52%100.03%100.17%100.00%
Dividend Paid to FCF----1.29%0.00%0.00%--------

Earnings

Report DateJun 25, 2015Aug 11, 2015Nov 5, 2015Mar 8, 2016May 10, 2016Aug 9, 2016Nov 10, 2016Mar 8, 2017May 10, 2017Aug 10, 2017Nov 9, 2017Mar 20, 2018May 9, 2018Aug 8, 2018Nov 7, 2018Mar 27, 2019May 8, 2019Aug 14, 2019Nov 6, 2019Mar 25, 2020May 13, 2020Aug 13, 2020Nov 12, 2020Mar 30, 2021May 17, 2021Aug 16, 2021Nov 15, 2021Mar 30, 2022May 12, 2022Aug 11, 2022Nov 10, 2022Mar 30, 2023May 15, 2023Aug 10, 2023Nov 9, 2023Mar 28, 2024May 9, 2024Aug 13, 2024Nov 12, 2024Mar 20, 2025May 7, 2025Aug 14, 2025Nov 7, 2025Mar 19, 2026May 15, 2026Aug 13, 2026Nov 6, 2026
EPS Estimate-88.00-88.00-56.00-56.00-56.00-56.00-56.00-80.00-56.00-88.00-64.00-2.00-56.00-51.60-45.20-30.40-40.40-37.60-31.20-23.00-19.20-24.20-21.60-16.40-12.20-9.20-9.60-12.00-12.40-12.40-7.60-6.80-6.60-4.92-2.93-2.58-2.211.55-0.77-0.89-0.98-0.79-0.54-0.09---
EPS Actual-2968.00-152.00-88.00-64.00-96.00-80.00-72.00-104.00-80.00-72.00-67.92-1.39-194.40-80.80-33.26-5.60-34.48-41.50-36.93-20.00-25.80-28.56-25.5235.20-11.86-8.76-12.35-11.20-8.74-8.28-7.70-6.29-10.860.61-1.89-2.52-1.780.78-0.87-2.991.90-3.260.62-0.98-2.11-0.38-
Surprise-3272.73%-72.73%-57.14%-14.29%-71.43%-42.86%-28.57%-30.00%-42.86%18.18%-6.13%30.50%-247.14%-56.59%26.42%81.58%14.65%-10.37%-18.37%13.04%-34.38%-18.02%-18.15%314.63%2.79%4.78%-28.65%6.67%29.52%33.23%-1.32%7.50%-64.55%112.40%35.49%2.33%19.46%-49.68%-12.99%-235.96%293.88%-312.66%214.81%-984.33%---
TimingAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours---

Key Statistics & Ratios

Market Cap741.07K
Enterprise Value-3.41M
Trailing P/E0.00
Forward P/E36.63
PEG Ratio-0.08
Price / Sales0.16
Price / Book1.62
EPS-4.54
Book Value0.29
Revenue (TTM)4.75M
Gross Profit (TTM)1.64M
EBITDA-3.79M
Profit Margin-234.53%
Operating Margin-34.37%
Return on Equity-430.93%
Return on Assets-34.76%
Shares Outstanding2.41M
Shares Float2.17M
Beta0.53
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 12.00
  • Strong Buy
    1

Ownership Breakdown

Institutions
18.68%
Insiders
0.15%
Retail / Other
81.17%

Top Institutional Holders

  • Armistice Capital, LLC
    159.39K6.62%
  • Sabby Management LLC
    114.55K4.75%
  • Geode Capital Management, LLC
    31.74K1.32%
  • Citadel Advisors Llc
    23.74K0.99%
  • Susquehanna International Group, LLP
    12.61K0.52%
  • State Street Corp
    12.15K0.50%
  • Vanguard Capital Management, LLC
    9.64K0.40%
  • Vanguard Fiduciary Trust Co
    4.39K0.18%
  • Tower Research Capital LLC
    3.94K0.16%
  • UBS Group AG
    8070.03%
  • SBI Securities Co Ltd
    1200.01%
  • Group One Trading, LLC
    180.00%
  • Genworth Financial Wealth Mgmt Inc
    50.00%
  • Morgan Stanley - Brokerage Accounts
    20.00%
  • Southern Michigan Bank & Trust
    20.00%
  • Citigroup Inc
    10.00%
  • HARBOUR INVESTMENTS, INC.
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    12.37K0.51%
  • Fidelity Series Total Market Index
    1.72K0.07%
  • Fidelity Total Market Index
    1.63K0.07%

Stock Splits

  • Mar 1, 20231:40
  • Jan 24, 20181:20